TNF and atherosclerosis: To summarise, our study indicates that the use of TNFα inhibitors may have a protective effect against subclinical atherosclerosis in patients with RA, given that patients on this biologic have a smaller CIMT than patients on other disease-modifying antirheumatic drugs.